1. Home
  2. INTT vs ZNTL Comparison

INTT vs ZNTL Comparison

Compare INTT & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTT
  • ZNTL
  • Stock Information
  • Founded
  • INTT 1981
  • ZNTL 2014
  • Country
  • INTT United States
  • ZNTL United States
  • Employees
  • INTT N/A
  • ZNTL N/A
  • Industry
  • INTT Semiconductors
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTT Technology
  • ZNTL Health Care
  • Exchange
  • INTT Nasdaq
  • ZNTL Nasdaq
  • Market Cap
  • INTT 102.6M
  • ZNTL 105.8M
  • IPO Year
  • INTT 1997
  • ZNTL 2020
  • Fundamental
  • Price
  • INTT $8.48
  • ZNTL $1.56
  • Analyst Decision
  • INTT Strong Buy
  • ZNTL Buy
  • Analyst Count
  • INTT 2
  • ZNTL 6
  • Target Price
  • INTT $12.00
  • ZNTL $6.53
  • AVG Volume (30 Days)
  • INTT 46.4K
  • ZNTL 683.0K
  • Earning Date
  • INTT 10-31-2025
  • ZNTL 11-11-2025
  • Dividend Yield
  • INTT N/A
  • ZNTL N/A
  • EPS Growth
  • INTT N/A
  • ZNTL N/A
  • EPS
  • INTT N/A
  • ZNTL N/A
  • Revenue
  • INTT $121,642,000.00
  • ZNTL $26,865,000.00
  • Revenue This Year
  • INTT N/A
  • ZNTL N/A
  • Revenue Next Year
  • INTT $10.38
  • ZNTL N/A
  • P/E Ratio
  • INTT N/A
  • ZNTL N/A
  • Revenue Growth
  • INTT N/A
  • ZNTL N/A
  • 52 Week Low
  • INTT $5.24
  • ZNTL $1.01
  • 52 Week High
  • INTT $9.77
  • ZNTL $4.44
  • Technical
  • Relative Strength Index (RSI)
  • INTT 62.54
  • ZNTL 50.37
  • Support Level
  • INTT $8.00
  • ZNTL $1.54
  • Resistance Level
  • INTT $8.44
  • ZNTL $1.84
  • Average True Range (ATR)
  • INTT 0.36
  • ZNTL 0.11
  • MACD
  • INTT 0.02
  • ZNTL 0.00
  • Stochastic Oscillator
  • INTT 93.60
  • ZNTL 35.14

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: